Gara Jalqabaatti › Hidradenitis Suppurativa
Qorannoo klinikaalii Hidradenitis Suppurativa Ameerikaa Keessatti hirmaatuu
Qorannoo 28 Hidradenitis Suppurativa f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Boston, MAQorannoo 9
- Tampa, FLQorannoo 7
- Miami, FLQorannoo 6
- New York City, NYQorannoo 5
- Birmingham, ALQorannoo 5
- Dallas, TXQorannoo 5
- Phoenix, AZQorannoo 5
- New Orleans, LAQorannoo 4
- Santa Clarita, CAQorannoo 4
- Scottsdale, AZQorannoo 4
- Durham, NCQorannoo 4
- Minneapolis, MNQorannoo 4
- Philadelphia, PAQorannoo 4
- Baltimore, MDQorannoo 3
- Evanston, ILQorannoo 3
- Cleveland, OHQorannoo 3
- Los Angeles, CAQorannoo 3
- Norfolk, VAQorannoo 3
- Detroit, MIQorannoo 3
- Huntington Beach, CAQorannoo 3
- Portsmouth, NHQorannoo 3
- Sandy Springs, GAQorannoo 3
- St. Louis, MOQorannoo 3
- Houston, TXQorannoo 3
- Bowling Green, KYQorannoo 3
- The Bronx, NYQorannoo 3
- Chicago, ILQorannoo 3
- West Lafayette, INQorannoo 3
- Baton Rouge, LAQorannoo 3
- San Francisco, CAQorannoo 3
Naannoon
- AlabamaQorannoo 5
- ArizonaQorannoo 7
- CaliforniaQorannoo 12
- FloridaQorannoo 10
- GeorgiaQorannoo 7
- IllinoisQorannoo 6
- IndianaQorannoo 5
- KentuckyQorannoo 5
- LouisianaQorannoo 6
- MarylandQorannoo 3
- MassachusettsQorannoo 10
- MichiganQorannoo 6
- MinnesotaQorannoo 4
- MissouriQorannoo 5
- New HampshireQorannoo 3
- New YorkQorannoo 7
- North CarolinaQorannoo 5
- OhioQorannoo 5
- PennsylvaniaQorannoo 6
- TexasQorannoo 8
- UtahQorannoo 3
- VirginiaQorannoo 3
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07783542A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07225569Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07828860Regulation of Inflammatory Genes in Hidradenitis Suppurativa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 89 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT05507125A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Dubartoota · Haaromfame 18-Ful-2026 · NCT06888193Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 75 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07049575Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06855498Targeting Nociceptors in Hidradenitis Suppurativa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT05403710Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06058520Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06326476Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07170917Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 hanga 17 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07213973A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07384975Myriad™ Augmented Soft Tissue Reconstruction Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ado-2026 · NCT05243966The Safety and Efficacy of Roflumilast Foam in HS
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ado-2026 · NCT07263230Pelashield™ PainGuard™ vs Restrata® in HS Surgery
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT07316192Radiotherapy for Refractory Hidradenitis Suppurativa
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Cam-2026 · NCT07414550Clinical and Biological Characteristics of Hidradenitis Suppurativa
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 13 fi ol · Saalaa hunda · Haaromfame 04-Cam-2026 · NCT03967600Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 10 fi ol · Saalaa hunda · Haaromfame 29-Elb-2026 · NCT04115566A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 71 · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT07123038A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Bit-2026 · NCT07244263The Ohio State University Dermatology Biorepository
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin hundi · Saalaa hunda · Haaromfame 27-Gur-2026 · NCT03146676A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 23-Mud-2025 · NCT070779021726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 17-Ful-2025 · NCT07155239Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.